Mochi Health is a US telehealth company delivering virtual, physician-led obesity medicine and metabolic care, including GLP-1 treatment, through personalised weight loss programmes.
Mochi Health is a telehealth company founded in 2022 that provides obesity medicine and metabolic care through a virtual platform. It delivers individualized, evidence-based weight loss programmes nationwide in the United States, with treatment plans developed and managed by board-certified physicians and registered dietitians who specialise in obesity medicine. Care is delivered remotely and is supported around the clock.
The company's core offering is a personalised weight loss programme that pairs medical and nutritional supervision with GLP-1 pharmacotherapy, including Semaglutide and Tirzepatide. Patients receive structured follow-up alongside medication access, with the stated aim of removing conventional barriers to care. Mochi Health reports an average weight loss of 10% at six months and a typical loss of 36 pounds in the first year.
Mochi Health reports serving more than 100,000 patients across the country, whose collective weight loss exceeds 5 million pounds. It states that five out of six members remain enrolled beyond their first month. The company describes its approach as patient-centric and treats weight as a complex health condition rather than a moral failing, with transparent pricing cited as part of its model.
